These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4963539)

  • 1. [Protective effect of highly polymerized desoxyribonucleic acid against medullary aplasia following intense anti-cancer chemotherapy or irradiation with radiocobalt].
    Wicart L; Vendrely C
    C R Acad Hebd Seances Acad Sci D; 1967 Feb; 264(6):857-60. PubMed ID: 4963539
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protective effect of highly polymerized deoxyribonucleic acid against bone marrow aplasia following intense anti-cancer chemotherapy or radiocobalt irradiation].
    Wicart L; Vendrely C
    C R Acad Hebd Seances Acad Sci D; 1967 Feb; 264(6):857-60. PubMed ID: 4989170
    [No Abstract]   [Full Text] [Related]  

  • 3. [New dimensions in the treatment of cancer?].
    Löwenberg B
    Ned Tijdschr Geneeskd; 1980 Mar; 124(10):337-9. PubMed ID: 6987542
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of radiological therapy combined with anticancer drugs].
    Takahashi N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Jul; 27(4):406-20. PubMed ID: 5237724
    [No Abstract]   [Full Text] [Related]  

  • 5. [Highly polymerized DNA. Curative and preventive treatment of therapeutic leukopenia. Result in 66 cases].
    Proux C; Toubiana CG
    Therapeutique; 1968 Nov; 44(9):539-41. PubMed ID: 5759643
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bone marrow protection by immunomodulators in antineoplastic chemotherapy].
    De Vita F; Della Vittoria Scarpati M; Diadema MR; Pilerci N; Catalano G
    G Ital Chemioter; 1991; 38(1-3):205-6. PubMed ID: 1365595
    [No Abstract]   [Full Text] [Related]  

  • 7. [Urinary excretion of formiminoglutamic acid as a test for folic acid deficiency determination in patients with cancer following surgical treatment, endoxan therapy and cobalt irradiation].
    Rezaković D; Hadziomerović V; Vobornik M
    Med Glas; 1967; 21(1):38-40. PubMed ID: 5584434
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiosensitizing action of ametohepazon on the irradiated tumor tissues. II. Preliminary clinical report.
    Niibe H; Tobe T; Kato T; Hirai E; Toda N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Nov; 27(8):995-1006. PubMed ID: 5245253
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of hematopoietic growth factors for high-dose chemotherapy and peripheral blood progenitor cell transplantation.
    Kanz L; Brugger W; Mertelsmann R
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):10-8. PubMed ID: 7528446
    [No Abstract]   [Full Text] [Related]  

  • 10. ["Highly polymerized" DNA in the treatment of bone marrow aplasia after radiotherapy or chemotherapy].
    Proux C; Toubiana CG
    Sem Ther; 1967 Nov; 43(9):552-3. PubMed ID: 5623403
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelosuppression and "conventional" chemotherapy: what price, what benefit?
    Canellos GP; Demetri GD
    J Clin Oncol; 1993 Jan; 11(1):1-2. PubMed ID: 8418220
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with radiocobalt bead therapy of uterine cancer].
    Hess P; Rosendahl J
    Strahlentherapie; 1965 Nov; 128(3):334-9. PubMed ID: 5873984
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the significance of radiocobalt pearls in the therapy of uterine neoplasms].
    Jánossy T; Rigó J
    Neoplasma; 1965; 12(4):441-4. PubMed ID: 5854416
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction of toxicity in cancer chemotherapy.
    Perry S
    Cancer Res; 1969 Dec; 29(12):2319-25. PubMed ID: 4905237
    [No Abstract]   [Full Text] [Related]  

  • 15. Autologous bone marrow transplantation. Current status and future directions.
    Cheson BD; Lacerna L; Leyland-Jones B; Sarosy G; Wittes RE
    Ann Intern Med; 1989 Jan; 110(1):51-65. PubMed ID: 2642282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proposal for deciding when to prophylactically administer bone marrow (granulocyte) stimulatory factors to patients receiving cytotoxic chemotherapy.
    Markman M
    J Cancer Res Clin Oncol; 1994; 120(11):629-30. PubMed ID: 7525591
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of cobalt-60 irradiation upon cell-mediated immunity.
    Gross L; Manfredi OL; Protos AA
    Radiology; 1973 Mar; 106(3):653-5. PubMed ID: 4684809
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the localization of the focus with gammatron 2 and on the problem of the motion technic of irradiation].
    Kahr E
    Strahlentherapie Sonderb; 1965; 61():176-82. PubMed ID: 5827118
    [No Abstract]   [Full Text] [Related]  

  • 19. [Moving field irradiation with wedge filters in Co-60 teletherapy].
    Welker K
    Strahlentherapie; 1965 Dec; 128(4):514-25. PubMed ID: 5885880
    [No Abstract]   [Full Text] [Related]  

  • 20. [1000 cases of pharyngeal cancer treated with radiocobalt. A 5 year follow-up study].
    Ennuyer A; Bataini P
    J Radiol Electrol Med Nucl; 1973 Jan; 54(1):7-17. PubMed ID: 4196354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.